EYPT
EyePoint, Inc.
Key Financials
Net Income
$-231962000
↓ 77.2%
Revenue
$31.4M
↓ 27.5%
Operating Income
$-243434000
↓ 66.9%
Total Assets
$364.0M
↓ 13.0%
EPS (Diluted)
$-3.17
↓ 36.6%
Total Liabilities
$57.9M
↓ 29.4%
Shareholders' Equity
$306.1M
↓ 9.0%
Cash & Equivalents
$101.8M
↑ 2.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/18/2026 | View on SEC |
| 8-K | 8/17/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G | 8/12/2026 | View on SEC |
| S-8 | 8/5/2026 | View on SEC |
| 10-Q | 8/5/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| SCHEDULE 13G | 7/31/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| SCHEDULE 13G/A | 7/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | EYPT |
| Company Name | EyePoint, Inc. |
| CIK | 1314102 |
| Sector | Laboratory Analytical Instruments |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-926-5000 |